Personalised trial for lung cancer could incorporate up to 14 different drugs
Fellowship and seed funding from Al Jalila Foundation
...more Clinical News
Kadcyla unaffordable for NHS, Lilly's Alimta also turned down in NSCLC maintenance setting, but BI's Giotrif is approved for NSCLC subset
Call for faster reviews for drugs that reduce costs
Regimen of three antivirals is needle free and interferon free
Sales rose nearly 17% in 2013
New building to include recruitment centre, advanced medical/surgical suite
And it could be big in healthcare.